E
Eugene Braunwald
Researcher at Brigham and Women's Hospital
Publications - 1758
Citations - 278949
Eugene Braunwald is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Myocardial infarction & TIMI. The author has an hindex of 230, co-authored 1711 publications receiving 264576 citations. Previous affiliations of Eugene Braunwald include Boston University & University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
Reduction of stent thrombosis in patients with acute coronary syndromes treated with rivaroxaban in ATLAS-ACS 2 TIMI 51
C. Michael Gibson,Anjan K. Chakrabarti,Jessica L. Mega,C. Bode,Jean-Pierre Bassand,Freek W.A. Verheugt,Deepak L. Bhatt,Shinya Goto,Marc Cohen,Satishkumar Mohanavelu,Paul Burton,Gregg W. Stone,Eugene Braunwald,Atlas-Acs Timi Investigators +13 more
TL;DR: Among stented patients with ACS treated with DAPT, the administration of twice-daily rivaroxaban 2.5 mg was associated with a reduction in stent thrombosis and mortality.
Journal ArticleDOI
Concomitant Use of Single Antiplatelet Therapy With Edoxaban or Warfarin in Patients With Atrial Fibrillation: Analysis From the ENGAGE AF‐TIMI48 Trial
Haiyan Xu,Christian T. Ruff,Robert P. Giugliano,Sabina A. Murphy,Francesco Nordio,Indravadan Patel,Minggao Shi,Michele Mercuri,Elliott M. Antman,Eugene Braunwald +9 more
TL;DR: Patients with AF who were selected by their physicians to receive SAPT in addition to an anticoagulant had a similar risk of stroke/SEE and higher rates of bleeding than those not receiving SAPT and Edoxaban exhibited similar relative efficacy and reduced bleeding compared to warfarin, with or without concomitant SAPT.
Journal ArticleDOI
Effects of increased arterial pressure and positive inotropic agents on the severity of myocardial ischemia in the acutely depressed heart.
TL;DR: Examination of the effects of systemic arterial hypertension, digitalis and isoproterenol on the extent of myocardial ischemic injury after acute pharmacologic depression of the dog heart found it to be limited to the nonfailing heart.
Journal ArticleDOI
Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF - TIMI 48 Trial.
Christina L. Fanola,Christian T. Ruff,Sabina A. Murphy,James Jin,Anil Duggal,Noe A. Babilonia,Piyamitr Sritara,Michele Mercuri,Pieter W. Kamphuisen,Elliott M. Antman,Eugene Braunwald,Robert P. Giugliano +11 more
TL;DR: In patients with atrial fibrillation who develop malignancy, the efficacy and safety profile of edoxaban relative to warfarin is preserved, and it may represent a more practical alternative.
Journal ArticleDOI
Prevalence and clinical outcomes of undiagnosed diabetes mellitus and prediabetes among patients with high-risk non–ST-segment elevation acute coronary syndrome
Roberto R. Giraldez,Robert M. Clare,Renato D. Lopes,Anthony J. Dalby,Dorairaj Prabhakaran,Gerard X. Brogan,Robert P. Giugliano,Stefan James,Jean-François Tanguay,Charles V. Pollack,Robert A. Harrington,Eugene Braunwald,L. Kristin Newby +12 more
TL;DR: Routine screening for undiagnosed diabetes may be useful since these patients seem to have worse short-term outcomes and deserve consideration of alternative management strategies.